1. Dipòsit Digital de la Universitat de Barcelona
  2. Recerca
  3. Bioquímica i Fisiologia
  4. Articles publicats en revistes (Bioquímica i Fisiologia)
Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/184034
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRayatpour, Atefeh-
dc.contributor.authorFarhangi, Sahar-
dc.contributor.authorVerdaguer Cardona, Ester-
dc.contributor.authorOlloquequi, Jordi-
dc.contributor.authorUreña Bares, Jesús Mariano-
dc.contributor.authorAuladell i Costa, M. Carme-
dc.contributor.authorJavan, Mohammad-
dc.date.accessioned2022-03-11T08:45:24Z-
dc.date.available2022-03-11T08:45:24Z-
dc.date.issued2021-10-11-
dc.identifier.issn1424-8247-
dc.identifier.urihttp://hdl.handle.net/2445/184034-
dc.description.abstractDespite the significant differences in pathological background of neurodegenerative diseases,epileptic seizures are a comorbidity in many disorders such as Huntington disease (HD), Alzheimer 'sdisease (AD), and multiple sclerosis (MS). Regarding the last one, specifically, it has been shownthat the risk of developing epilepsy is three to six times higher in patients with MS compared tothe general population. In this context, understanding the pathological processes underlying thisconnection will allow for the targeting of the common and shared pathological pathways involvedin both conditions, which may provide a new avenue in the management of neurological disorders.This review provides an outlook of what is known so far about the bidirectional association betweenepilepsy and MS-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherMDPI-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3390/ph14101031-
dc.relation.ispartofPharmaceuticals, 2021, vol. 14, num. 10, p. 1031-
dc.relation.urihttps://doi.org/10.3390/ph14101031-
dc.rightscc-by (c) Rayatpour, Atefeh et al., 2021-
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/-
dc.sourceArticles publicats en revistes (Bioquímica i Fisiologia)-
dc.subject.classificationMalalties neurodegeneratives-
dc.subject.classificationMetabolisme cel·lular-
dc.subject.otherNeurodegenerative Diseases-
dc.subject.otherCell metabolism-
dc.titleThe Cross Talk between Underlying Mechanisms of Multiple Sclerosis and Epilepsy May Provide New Insights for More Efficient Therapies-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec717135-
dc.date.updated2022-03-11T08:45:24Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
Appears in Collections:Articles publicats en revistes (Bioquímica i Fisiologia)
Articles publicats en revistes (Biologia Cel·lular, Fisiologia i Immunologia)

Files in This Item:
File Description SizeFormat 
717135.pdf1.75 MBAdobe PDFView/Open
Show simple item record


This item is licensed under a Creative Commons License Creative Commons